The global Cancer Registry Software market size is expected to be worth around US$ 103.10 million by 2028, according to a new report by Vision Research Reports.
The global Cancer Registry Software market size was valued at US$ 47.9 million in 2020 and is anticipated to grow at a CAGR of 10.10% during forecast period 2021 to 2028.
Growing incidence of cancer is expected to aid growth over the forecast period. Currently, cancer is the second leading cause of death globally, and according to WHO, around 70% of the deaths occur in low- and middle-income countries.
Moreover, rising adoption of Electronic Health Records (EHRs) in developed countries and increasing need for cancer registries for post-marketing surveillance are among the factors further anticipated to boost the demand for cancer registry software in the coming years. Market players are constantly involved in software updation in an attempt to minimize security risks and provide efficient software, thereby increasing market visibility and adoption. For instance, in April 2018, Elekta invested in PalabraApps LLC to improve its MOSAIQ Oncology Information System software.
Increasing number of clinical trials being conducted by major pharmaceutical and biotechnological companies is expected to drive the market over the forecast period. Cancer registry data helps in tracking patients for clinical trials. Moreover, the affected locations for any specific type of cancer can be identified by using this software. Major pharmaceutical companies are increasingly preferring cancer registry software owing to less requirement of internal staff, increased cost-effectiveness, and efficient management of resources, which is further widening the scope for growth.
Based on software, the market is segmented into standalone and integrated software. The standalone segment held the largest revenue share as of 2020 owing to its advanced features and easy-to-use tools. Moreover, it allows the processing of registry data and multiple system usages, which is further boosting the market. The automatic upgrade feature of standalone software helps reduce IT overhead costs. CAN REG 5 is standalone software launched by WHO, which is open-source with features such as automated system backup and data restoration.
Integrated software is expected to exhibit significant growth over the forecast period owing to the increasing need for integrating software with a regional oncology network. This will help track affected geographic locations and evaluate the clinical intervention. It will further help gain information on disease burden and the effectiveness of treatment programs. Moreover, integration with screening archives is also necessary to identify screen-detected cancers and improve evaluation techniques. These factors are expected to propel the growth of this segment in the coming years.
The on-premise segment held the largest share of the deployment model market as of 2020. Increase in adoption of on-premise solutions by hospitals & research institutes due to their various benefits such as the lower risk of external attacks and high data security against breach are boosting the revenue. These solutions are also helpful for heavy data file transfers and system upgrades. Research institutes mostly use on-premise models due to the confidentiality of their data and advanced features associated with these models.
The cloud-based segment is expected to exhibit lucrative growth over the forecast period owing to reduced installment charges and IT overhead costs. Cloud-based software mostly provides a platform-as-a-service solution. Major advantages of a cloud-based system include real-time data analysis and integration by standard guidelines. Companies are working toward increasing data safety of this model, which is expected to propel market growth soon.
Based on components, the market is segmented into commercial and public. The commercial segment held the largest revenue share as of 2020 owing to its advantage of data safety as compared to the public database. The commercial database is mostly in compliance with government standards and coding. The data is also highly structured and easy to track. Commercial systems allow data exchange among government research organizations such as CDC and central cancer registries.
The government & third party held the largest revenue share of the end-user segment as of 2020. Increasing the implementation of this software by governments of both developed and developing countries to reduce the cancer burden is fueling the growth of the market. Governments can easily track the most affected areas using this registry and can take preventive measures. Moreover, increasing government funding in hospitals for the implementation of software is boosting segment revenue.
Research institutes segment is expected to grow at a lucrative rate over the forecast period due to increasing research initiatives being undertaken by government & private organizations to address the increasing incidence of cancer. These institutes use software to track patients for and check the efficacy of treatment programs. Pharmaceutical, biotechnology, & medical devices companies segment is also expected to exhibit significant growth over the forecast period owing to increasing R&D by these companies for better treatment outcomes.
The Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing government initiatives being undertaken in this region. The Ministry of Health Labour and Welfare in Japan has undertaken initiatives to improve the existing healthcare infrastructure. China has also launched its 12th Five-year Plan to upgrade Regional Healthcare Information Networks (RHINs) for rural citizens of the country. Moreover, the shift of pharmaceutical companies to low-cost manufacturing countries such as China and India is further propelling the growth of the Asia Pacific market. However, weak infrastructure, low quality, and insufficient coverage are some of the major factors, which may limit growth soon.
Electronic Registry Systems Inc.
Deployment Model Outlook
Government & third party
Hospital & medical practice
Pharma biotech & medical device companies
Middle East & Africa
The Cancer Registry Software market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Cancer Registry Software market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Cancer Registry Software market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Registry Software market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Cancer Registry Software market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Cancer Registry Software capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Cancer Registry Software by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Cancer Registry Software market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Cancer Registry Software market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Cancer Registry Software market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Cancer Registry Software industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Cancer Registry Software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Cancer Registry Software market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Cancer Registry Software market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Cancer Registry Software market. These factors have benefited the growth of the global market for Cancer Registry Software. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Cancer Registry Software. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Cancer Registry Software are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Cardiovascular Repair And Reconstruction Devices Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Medical Cyclotron Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Wireless Health Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Hepatitis Therapeutics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...
Procedure Trays Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030Read more...